Skip to main content

Table 1 Clinical characteristics of the patient population in this study

From: Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection

Patient Age Sex Antibiotics Pre C. difficile infection Antibiotics used to treat C. difficile infection Resolution of C. difficile infection
1 35 F Co-amoxiclavMetronidazole Metronidazole, Vancomycin, Fidaxomicin No
3 35 F As above As above Yes
2 24 F Erythromycin Azithromycin Vancomycin, Fidaxomicin Yes
4 54 F Co-amoxiclav Metronidazole, Vancomycin, Fidaxomicin Yes
5 69 F Tazobactam, Piperacillin Co-amoxiclav Metronidazole Vancomycin Fidaxomicin Yes
6 65 F Flucoloxacillin Calvepen Benzylpenicillin Co-amoxiclav Metronidazole, Vancomycin Yes
7 90 F Cefuroxime Cephalexin Metronidazole Vancomycin Fidaxomicin Yes
8 58 F Tazobactam Piperacillin Vancomycin, Meropenem Metronidazole Vancomycin Fidaxomicin Yes
10 22 M None Vancomycin Yes
11 68 M Tazobactam Piperacillin Metronidazole Vancomycin Fidaxomicin Yes